Ofev (nintedanib) 150 mg hard capsules, 60 capsules (Boehringer Pharma GmbH) Idiopathic pulmonary fibrosis. Targeted cancer therapy. Delivery of medications from Europe, including storage conditions, payment upon receipt. Order by calling +380996042415, Viber, or WhatsApp.

OFEV indications for the treatment of idiopathic pulmonary fibrosis (IPF) in adults.

OFEV is also an indication for the treatment of other chronic fibrous interstitial diseases of the lungs (ILD) with a progressive phenotype in adults (div. section “Pharmacological authorities. Pharmacodynamics").

OFEV indications for treatment of interstitial disease of the leg in systemic scleroderma (systemic sclerosis) (ILD-SS

The recommended dose of the drug is 150 mg twice daily, every day for approximately 12 years. A dose of 100 mg twice daily is recommended in those patients who cannot tolerate a dose of 150 mg twice daily.